Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


19.04.2021

1 Am J Respir Crit Care Med
1 Antimicrob Agents Chemother
1 Lancet
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med


  1. Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2021;203:1045.
    PubMed        


    Antimicrob Agents Chemother

  2. LIN WH, Lee WT, Tsai HY, Jou R, et al
    Disputed rpoB mutations in Mycobacterium tuberculosis and tuberculosis treatment outcomes.
    Antimicrob Agents Chemother. 2021 Apr 12. pii: AAC.01573.
    PubMed         Abstract available


    Lancet

  3. WALTER KS, Martinez L, Arakaki-Sanchez D, Sequera VG, et al
    The escalating tuberculosis crisis in central and South American prisons.
    Lancet. 2021 Apr 8. pii: S0140-6736(20)32578.
    PubMed         Abstract available


    PLoS One

  4. SPEKKER O, Kis L, Deak A, Makai E, et al
    An unusual case of childhood osteoarticular tuberculosis from the Arpadian Age cemetery of Gyorszentivan-Revhegyi tag (Gyor-Moson-Sopron county, Hungary).
    PLoS One. 2021;16:e0249939.
    PubMed         Abstract available

  5. CHAVES-TORRES NM, Fadul S, Patino J, Netto E, et al
    Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0249565.
    PubMed         Abstract available

  6. MCCALLAN L, Brooks C, Barry C, Couzens C, et al
    Serological test performance for bovine tuberculosis in cattle from herds with evidence of on-going infection in Northern Ireland.
    PLoS One. 2021;16:e0245655.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: